ACUMEN PHARMACEUTICALS INC. - COMMON STOCK
1.7900
24-十二月-24 13:00:00
15 分钟延时
股票
+0.0200
+1.13%
今日范围
1.7300 - 1.8300
ISIN
N/A
来源
NASDAQ
-
Acumen Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
19 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the H.C. Wainwright Annual Global Investment Conference
06 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
08 8月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 8, 2023
01 8月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Acumen Announces Pricing of Upsized $130 Million Public Offering
18 7月 2023 22:31:16 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
17 7月 2023 16:53:41 条件 Nasdaq GlobeNewswire
-
17 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
09 5月 2023 07:00:03 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference
04 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023
02 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
28 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
27 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
22 3月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
20 3月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
08 3月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
04 1月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
14 11月 2022 16:01:01 条件 Nasdaq GlobeNewswire